GPT and neutropenia: Lastly, a statistically significant exposure–response relationship between bosutinib exposure and the probability of Grade >2 severity was observed for thrombocytopenia, whereas no significant exposure–response relationship between bosutinib exposure and incidence for elevated ALT and neutropenia was observed.